期刊文献+

喉癌组织中Ccbe1、VEGF-D的表达变化及意义 被引量:2

Expression changes of Ccbe1 and VEGF-D in human laryngeal carcinoma tissue and the significance
下载PDF
导出
摘要 目的观察喉癌组织中胶质和钙结合EGF区域1(Ccbe1)、血管内皮生长因子D(VEGF-D)的表达变化,并探讨其意义。方法采用免疫组化法检测45例喉癌组织(喉癌组)及20例因声带息肉手术切除的喉良性组织(良性组)中的Ccbe1、VEGF-D,分析两指标间及与喉癌临床病理参数、染色计数淋巴管密度(LVD)、CD34染色计数微血管密度(MVD)的相关性,观察喉癌组Ccbe1表达阳性及阴性者生存时间。结果喉癌组Ccbe1、VEGF-D的阳性表达率分别为51.1%、60%,对照组分别为20%、25%,两组比较P均<0.05。Ccbe1表达与喉癌TNM分期、淋巴结转移相关(P均<0.05)。喉癌组织中Ccbe1与VEGF-D表达呈正相关(r=0.381,P<0.05)。Ccbe1和VEGF-D表达均与MVD、LVD密切相关(P均<0.05)。Ccbe1阳性者生存时间为(43.94±5.47)个月,阴性者生存时间为(61.09±4.75)个月,两者比较P<0.05;Ccbe1阳性表达与生存曲线呈负相关(P<0.05)。结论 Ccbe1能够通过上调VEGF-D表达促进喉癌淋巴管生成和血管生成,检测Ccbe1表达可成为判断喉癌预后新的生物学指标。 Objective To observe the expression changes of collagen and calcium binding EGF domains 1 ( Ccbe! ) and vascular endothelial growth factor D (VEGF-D) in patients with laryngeal cancer, and to investigate their significance. Methods Forty-five specimens of the laryngeal cancer tissue ( group A) and 20 specimens of benign laryngeal tissue (group B) were studied. The protein expression of Ccbel and VEGF-D were detected by immunohistochemistry, LVD was evaluated by staining, MVD was evaluated by immunohistochemistry with CD ; the correlation analysis was made between two factors and clinical parameters, LYD, MVD. The survival time of the Ccbel positive and negative groups in laryngeal carcinoma was observed. Results The positive protein expression of Ccbel and VEGF-D were 51.1% and 60% in tumor tissue, and those in the normal tissue were 20% and 25%, comparison of two group were both P 〈 0.05. The expression of Ccbel was significantly correlated with TNM stage and lymphatic metastasis (P 〈 0.05 ). The expression of Ccbe-1 was sig- nificantly positive correlated with the expression of VEGF-D (r = 0.381, P 〈 0.05). The expression of Ccbel and EGF-D was significantly correlated with MVD and LVD (P 〈 0.05 ). The survival time in the Ccbel positive group was 43.94 ± 5.47 months, the survival time in the Ccbel negative group was 61.09 ± 4.75 months (P 〈 0.05 ). The positive expression of Ccbel was negatively correlated with the survival curve (P 〈 0.05 ). Conclusions Ccbel promote lymphangiogenesis and angiogenesis in laryngeal cancer by up-regulating the expression of VEGF-D. Detection of Ccbel protein may be helpful for judging prognosis in laryngeal cancer.
机构地区 牡丹江医学院
出处 《山东医药》 CAS 2013年第23期21-23,共3页 Shandong Medical Journal
基金 黑龙江省教育厅科研项目(12531745) 黑龙江省卫生厅科研项目(2012-282)
关键词 喉癌 胶质和钙结合EGF区域1 血管内皮生长因子 免疫组织化学 laryngeal carcinoma collagen and calcium binding EGF domains 1 vascular endothelial growth factor immunohistocbemistry
  • 相关文献

参考文献10

  • 1李文媛,王莹,李明秋.VEGFR-3在喉癌组织中的表达及临床意义[J].山东医药,2011,51(27):22-24. 被引量:2
  • 2王莹,李文媛,杨春壮,贾桦,佟晓杰.喉癌中血管内皮素-1的表达与血管内皮生长因子-C、淋巴管生成及预后的关系[J].解剖学杂志,2011,34(6):758-762. 被引量:1
  • 3Hogan BM, Bos FL, Bussmann J, et al. Ccbel is required for em-bryonic lymphangiogenesis and venous sprouting[ J]. Nature Gen-et, 2009,41(4):396-398.
  • 4Alders M,Hogan BM, Gjini E, et al. Mutations in CCBE1 causegeneralized lymph vessel dysplasia in humans [ J ]. Nature Genet,2009,41(12):1272-1274.
  • 5Bos FL, Caunt M, Peterson J, et al. CCBE1 is essential for mam-malian lymphatic vascular development and enhances the lym-phangiogenic effect of vascular endothelial growth factor-C in vivo[J]. Circ Res,2011,109(5) :486491.
  • 6Hauptmann S, Denkert C, Koch I, et al. Genetic alterations in ep-ithelial ovarian tumors analyzed by comparative genomic hybridiza-tion[J]. Hum Pathol, 2002,33(6) :632-641.
  • 7Barton CA, Gloss BS, Qu W, et al. Collagen and calcium-bindingEGF domains 1 are frequently inactivated in ovarian cancer by ab-errant promoter hypermethylation and modulates cell migration andsurvival[ J]. Br J Cancer, 2010,102(1):87-96.
  • 8Hagerling R, Pollmann C, Andreas M, et al. A novel multistepmechanism for initial lymphangiogenesis in mouse embryos basedon ultramicroscopy[ J]. EMBO J, 2013,32(5) :629-644.
  • 9Wang J, Guo Y, Wang B, et al. Lymphatic microvessel densityand vascular endothelial growth factor-C and -D as prognostic fac-tors in breast cancer: a systematic review and meta-analysis of theIiterature[ J]. Mol Biol Rep, 2012,39(12) :11153-11165.
  • 10Kashimaa K, Watanabe M,Satoh Y, et al. Inhibition of lymphaticmetastasis in neuroblastoma by a novel neutralizing antibody to vas-cular endothelial growth factor-D[ J] . Cancer Sci, 2012,103(12):2144-2152.

二级参考文献20

  • 1Hsu JY, Wakelee HA. Monoclonal antibodies targeting vascular en- dothelial growth factor: current status and future challenges in canc- er therapy[ J]. BioDrugs, 2009,23(5) :289-304.
  • 2Stacker SA, Baldwin ME, Achen MG. The role of tumor lym- phangiogvnosis in metastatic spread[J]. FASEB J, 2002, 16(9) : 922-934.
  • 3Achen MG, Stacker SA. Molecular control of lymphatic metastasis [J]. Ann N Y Acad Sci, 2008,(1131) :225-234.
  • 4Juttner S, Wissmarm C, Jons T, et al. Vascular endothelialgrowth factor-D and its receptor VEGFRo3 : two novel independent prognos- tic markers in gastric adenocarcinoma[ J]. J Clin Oncol, 2006,24 (2) :228-240.
  • 5Debinski W, Slagle-Webb B, Achen MG, et al. VEGF-D is an X- linked/AP-1 regulated putative onco-angiogen in human glioblastoma multifonne[J]. Mol Med, 2001,7(9) :598-608.
  • 6Baek SK, Jung KY. Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglot- tic squamous cell carcinoma[ J ]. Laryngoscope, 2009,119 ( 7 ) : 1325-1330.
  • 7Hinojaz-Gutierrez A, Femandez-Contreras ME, Gonzalez-Gonzalez R , et al. Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 NO laryngopha- ryngal squamous cell carcinoma [ J ]. Ann Surg Oncol, 2007,14 ( 1 ) :248-257.
  • 8Baek SK, Jung KY, Lee SH, et al, Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma [J]. Laryngoscope, 2009,119(7) : 1325-1330.
  • 9Hinojar-Gutierrez A, Femdndez-Contreras M E, Gonzalez-Gonzalez R, et al. Intratumoral lymphatic vessels and VEGF-C expression are predictive factors of lymph node relapse in T1-T4 NO laryngopharyngeal squamous cell carcinoma[J]. Ann Surg Oncol, 2007,14(1) :248-257.
  • 10Nelson J, Bagnato A, Battistini B, et al. The endothelin axis., emerging role in cancer [J]. Nat Rev Cancer, 2003,3(2) : 110-116.

共引文献1

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部